je.st
news
Pharmaco-Kinesis Corporation Develops First Combinatorial Nano-Drug TNT
2013-04-30 09:00:00| drugdiscoveryonline News Articles
Pharmaco-Kinesis Corporation (PKC), an advanced medical device company developing smart implantable pumps and medications for local drug delivery, recently reported development of the first combinatorial nano-drug product candidate, a combination of Temozolomide (Merck & Co.) and Thalidomide (Celgene) nanoparticles to be tested for treatment of gliomas and other cancers
Tags: corporation
develops
tnt
combinatorial
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||